NPI: 1891799227 · LOUISVILLE, KY 40202 · General Acute Care Hospital · NPI assigned 06/13/2005
Authorized official GAST, SHELLEY controls 20+ related entities in our dataset. Read more
| Authorized Official | GAST, SHELLEY (VP MANAGED CARE) |
| Parent Organization | NORTON HOSPITALS INC |
| NPI Enumeration Date | 06/13/2005 |
Other providers sharing the same authorized official: GAST, SHELLEY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,219 | $17K |
| 2019 | 11,226 | $36K |
| 2020 | 6,192 | $75K |
| 2021 | 38,845 | $1.32M |
| 2022 | 379,721 | $25.73M |
| 2023 | 1,529,843 | $144.10M |
| 2024 | 1,204,998 | $127.72M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 82,795 | 66,586 | $25.52M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 90,211 | 78,673 | $24.81M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 17,425 | 14,832 | $11.48M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 33,977 | 20,500 | $9.78M |
| J9271 | Injection, pembrolizumab, 1 mg | 1,056 | 760 | $9.54M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 36,822 | 32,646 | $8.77M |
| C1776 | Joint device (implantable) | 880 | 640 | $8.24M |
| 70450 | Computed tomography, head or brain; without contrast material | 19,606 | 15,226 | $6.40M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11,025 | 9,653 | $6.20M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 3,888 | 2,627 | $5.94M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 49,359 | 44,591 | $5.81M |
| J3490 | Unclassified drugs | 99,742 | 25,842 | $5.44M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 6,386 | 5,539 | $4.06M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 6,136 | 4,572 | $3.88M |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 4,988 | 4,530 | $3.41M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5,575 | 3,835 | $3.37M |
| 96375 | Therapeutic injection; each additional sequential IV push | 28,995 | 19,402 | $3.21M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6,802 | 5,515 | $3.12M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 6,203 | 5,223 | $3.12M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 54,864 | 26,139 | $2.48M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 29,410 | 12,042 | $2.40M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 46,072 | 35,822 | $2.34M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7,051 | 6,608 | $2.17M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5,208 | 3,357 | $2.10M |
| 77386 | 4,590 | 416 | $2.05M | |
| 72141 | 2,815 | 2,491 | $1.98M | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 4,929 | 2,135 | $1.95M |
| 72125 | Computed tomography, cervical spine; without contrast material | 4,770 | 4,107 | $1.95M |
| 96361 | Intravenous infusion, hydration; each additional hour | 31,007 | 18,855 | $1.85M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 8,231 | 7,309 | $1.76M |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 4,972 | 3,342 | $1.73M |
| 80053 | Comprehensive metabolic panel | 139,764 | 93,208 | $1.72M |
| 76770 | 7,651 | 7,176 | $1.71M | |
| 71045 | Radiologic examination, chest; single view | 31,660 | 23,028 | $1.61M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 34,342 | 28,952 | $1.60M |
| G0378 | Hospital observation service, per hour | 16,992 | 8,440 | $1.53M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,193 | 1,021 | $1.53M |
| 71046 | Radiologic examination, chest; 2 views | 17,876 | 15,730 | $1.49M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 10,214 | 5,331 | $1.49M |
| 58571 | 757 | 297 | $1.46M | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7,734 | 7,087 | $1.31M |
| 74019 | 9,383 | 8,770 | $1.28M | |
| 93458 | 701 | 321 | $1.27M | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 25,811 | 11,255 | $1.23M |
| 72131 | 2,817 | 2,275 | $1.17M | |
| 71250 | 4,766 | 3,654 | $1.16M | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 2,201 | 1,958 | $1.15M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1,299 | 1,178 | $1.15M |
| 93017 | 3,307 | 2,995 | $1.13M | |
| 36415 | Collection of venous blood by venipuncture | 198,260 | 72,004 | $1.11M |
| 47562 | 853 | 527 | $1.10M | |
| 70496 | 1,962 | 1,626 | $1.10M | |
| 93320 | 3,372 | 3,153 | $1.09M | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 2,286 | 1,312 | $1.06M |
| 58661 | 700 | 526 | $1.04M | |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 1,049 | 970 | $1.03M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 2,422 | 1,627 | $985K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 11,663 | 8,022 | $975K |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 516 | 343 | $967K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 143,952 | 101,520 | $960K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,439 | 6,351 | $954K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 28,959 | 17,665 | $944K |
| 70498 | 1,918 | 1,632 | $916K | |
| 76830 | Ultrasound, transvaginal | 4,894 | 4,348 | $897K |
| 44970 | 526 | 456 | $897K | |
| J2350 | Injection, ocrelizumab, 1 mg | 53 | 37 | $895K |
| 74018 | 7,599 | 6,872 | $876K | |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 147 | 126 | $874K |
| 62323 | 3,169 | 1,676 | $864K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3,496 | 3,078 | $858K |
| C1762 | Connective tissue, human (includes fascia lata) | 287 | 222 | $834K |
| 95713 | 2,702 | 1,559 | $834K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 10,533 | 8,916 | $811K |
| 72146 | 1,153 | 1,024 | $770K | |
| 93975 | 3,429 | 3,112 | $755K | |
| 70486 | 1,844 | 1,672 | $753K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,450 | 1,304 | $733K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,356 | 1,140 | $723K |
| 64615 | 5,208 | 3,629 | $723K | |
| 70491 | 1,912 | 1,426 | $694K | |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 106 | 99 | $684K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,723 | 1,138 | $678K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,893 | 1,804 | $659K |
| 83880 | 19,748 | 17,158 | $650K | |
| 64643 | 747 | 656 | $638K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8,928 | 8,674 | $635K |
| C1769 | Guide wire | 4,013 | 3,361 | $634K |
| 74178 | 1,153 | 761 | $624K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 2,365 | 1,458 | $615K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 4,097 | 3,863 | $599K |
| 93971 | 3,534 | 3,261 | $590K | |
| 76536 | 3,788 | 3,478 | $587K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 10,270 | 9,295 | $584K |
| C1889 | Implantable/insertable device, not otherwise classified | 301 | 251 | $574K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 20,494 | 19,485 | $568K |
| 27447 | 699 | 139 | $563K | |
| 73221 | 1,122 | 1,035 | $562K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 152 | 131 | $561K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12,059 | 3,809 | $554K |
| J0185 | Injection, aprepitant, 1 mg | 1,811 | 1,068 | $553K |
| 72156 | 803 | 637 | $543K | |
| 74183 | 1,005 | 723 | $543K | |
| 72197 | 877 | 660 | $540K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 11,739 | 10,096 | $538K |
| C1874 | Stent, coated/covered, with delivery system | 198 | 178 | $535K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 3,271 | 2,812 | $535K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,580 | 4,651 | $534K |
| 36512 | 1,081 | 508 | $534K | |
| 76801 | 3,936 | 3,304 | $523K | |
| 73630 | 5,677 | 4,706 | $514K | |
| 84484 | 31,915 | 22,963 | $492K | |
| 95812 | 1,619 | 1,534 | $489K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 672 | 544 | $487K |
| J9173 | Injection, durvalumab, 10 mg | 137 | 50 | $476K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 958 | 773 | $468K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 23,751 | 20,751 | $465K |
| 96415 | 2,607 | 1,875 | $462K | |
| J1756 | Injection, iron sucrose, 1 mg | 6,004 | 2,752 | $453K |
| 72158 | 752 | 589 | $450K | |
| 93970 | 1,965 | 1,813 | $431K | |
| 77334 | 866 | 504 | $428K | |
| 54161 | 1,028 | 985 | $423K | |
| 76642 | 4,445 | 4,217 | $422K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,773 | 1,600 | $418K |
| 93325 | 4,434 | 4,109 | $413K | |
| C1781 | Mesh (implantable) | 538 | 413 | $398K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,171 | 970 | $384K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 12,674 | 7,317 | $380K |
| 95716 | 856 | 669 | $370K | |
| 76870 | 1,943 | 1,783 | $369K | |
| 72157 | 551 | 472 | $369K | |
| 64642 | 698 | 523 | $358K | |
| 73130 | 5,094 | 3,790 | $355K | |
| 73610 | 4,677 | 3,917 | $351K | |
| 59025 | Fetal non-stress test | 5,263 | 4,289 | $347K |
| 73562 | 4,696 | 3,358 | $347K | |
| 43235 | 686 | 462 | $345K | |
| 54300 | 561 | 546 | $342K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 12,501 | 10,188 | $337K |
| 96367 | 3,216 | 1,586 | $337K | |
| 77066 | Tomosynthesis, mammo | 2,606 | 2,388 | $330K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,117 | 2,584 | $328K |
| 62321 | 908 | 573 | $325K | |
| 73030 | 4,240 | 2,931 | $323K | |
| 64721 | 732 | 455 | $322K | |
| 36561 | 776 | 251 | $322K | |
| J0897 | Injection, denosumab, 1 mg | 240 | 158 | $321K |
| 36430 | 1,765 | 1,133 | $317K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 126 | 96 | $316K |
| 80048 | Basic metabolic panel (calcium, ionized) | 23,118 | 14,646 | $316K |
| 72128 | 962 | 797 | $315K | |
| 74455 | 1,445 | 1,357 | $314K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,265 | 1,420 | $301K |
| 95700 | 2,377 | 2,123 | $299K | |
| 77412 | 1,393 | 177 | $299K | |
| 77295 | 418 | 244 | $294K | |
| 70544 | 862 | 679 | $293K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 1,071 | 843 | $293K |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral | 520 | 391 | $293K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 10,020 | 9,094 | $292K |
| 58558 | 451 | 285 | $291K | |
| 96376 | 3,439 | 2,500 | $288K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,229 | 1,063 | $284K |
| 88342 | 4,395 | 3,788 | $284K | |
| J2997 | Injection, alteplase recombinant, 1 mg | 2,576 | 859 | $272K |
| 96417 | 1,880 | 1,124 | $270K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,817 | 1,774 | $269K |
| 88341 | 1,699 | 1,337 | $268K | |
| 78431 | 215 | 153 | $259K | |
| 20680 | 293 | 231 | $257K | |
| 93225 | 1,560 | 1,274 | $255K | |
| 83735 | 30,991 | 22,071 | $255K | |
| 74174 | 448 | 339 | $253K | |
| 51600 | 1,402 | 1,341 | $251K | |
| 95782 | 393 | 327 | $250K | |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 187 | 51 | $249K |
| 52332 | 604 | 276 | $247K | |
| 77300 | 837 | 517 | $246K | |
| 73590 | 3,333 | 2,769 | $246K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,922 | 1,667 | $245K |
| 78264 | 856 | 587 | $244K | |
| 49083 | 768 | 266 | $239K | |
| 73090 | 3,342 | 2,812 | $238K | |
| 50590 | 139 | 78 | $236K | |
| 87486 | 8,580 | 7,833 | $232K | |
| 75574 | 506 | 401 | $230K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4,096 | 1,636 | $229K |
| 97161 | 5,232 | 2,885 | $223K | |
| 87581 | 8,448 | 7,829 | $220K | |
| 77336 | 2,510 | 814 | $217K | |
| 19083 | 522 | 306 | $215K | |
| 49650 | 63 | 52 | $213K | |
| 64644 | 460 | 305 | $212K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7,822 | 7,141 | $211K |
| 95811 | 454 | 406 | $211K | |
| 51728 | 873 | 834 | $210K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7,718 | 7,131 | $207K |
| 93351 | 495 | 380 | $204K | |
| 73110 | 2,871 | 2,367 | $203K | |
| 95886 | 1,080 | 1,032 | $203K | |
| 72100 | 2,202 | 1,859 | $198K | |
| J2785 | Injection, regadenoson, 0.1 mg | 1,524 | 1,426 | $194K |
| 78227 | 575 | 396 | $193K | |
| 95813 | 589 | 557 | $188K | |
| C1768 | Graft, vascular | 79 | 56 | $186K |
| 84443 | Thyroid stimulating hormone (TSH) | 10,248 | 9,217 | $182K |
| 83690 | 27,331 | 23,675 | $181K | |
| 74230 | 1,131 | 904 | $181K | |
| 73700 | 617 | 507 | $179K | |
| 77062 | 2,769 | 2,240 | $179K | |
| 72040 | 1,902 | 1,628 | $177K | |
| 27130 | 154 | 38 | $175K | |
| 88307 | 1,409 | 1,172 | $175K | |
| 93798 | 5,117 | 786 | $171K | |
| 73560 | 2,125 | 1,728 | $169K | |
| 51784 | 902 | 872 | $166K | |
| J2704 | Injection, propofol, 10 mg | 57,622 | 30,302 | $164K |
| 72110 | 1,548 | 1,296 | $163K | |
| 36593 | 964 | 638 | $161K | |
| 10060 | 871 | 783 | $161K | |
| 76882 | 1,291 | 1,193 | $161K | |
| 12011 | 1,427 | 1,351 | $159K | |
| 84703 | 26,156 | 22,608 | $157K | |
| 86850 | 15,328 | 12,035 | $156K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,115 | 942 | $156K |
| 77065 | Tomosynthesis, mammo | 2,191 | 1,816 | $155K |
| 70487 | 353 | 308 | $154K | |
| 73070 | 2,361 | 1,932 | $154K | |
| C1726 | Catheter, balloon dilatation, non-vascular | 502 | 441 | $153K |
| 80061 | Lipid panel | 9,874 | 4,497 | $153K |
| J9299 | Injection, nivolumab, 1 mg | 28 | 13 | $153K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 353 | 260 | $153K |
| 74240 | 993 | 892 | $153K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,759 | 1,641 | $150K |
| 96411 | 1,128 | 673 | $147K | |
| 54640 | 196 | 184 | $144K | |
| 49591 | 123 | 108 | $143K | |
| 94660 | 968 | 544 | $143K | |
| 81025 | 20,151 | 17,833 | $142K | |
| 77290 | 940 | 408 | $140K | |
| 88185 | 514 | 371 | $139K | |
| 97535 | Self-care/home management training, each 15 minutes | 5,690 | 3,249 | $138K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 5,675 | 5,259 | $136K |
| 12001 | 1,200 | 1,114 | $135K | |
| 77080 | 2,136 | 1,631 | $134K | |
| 55175 | 463 | 446 | $133K | |
| 73521 | 1,218 | 1,139 | $132K | |
| 73502 | 1,854 | 1,413 | $132K | |
| 76885 | 967 | 921 | $131K | |
| 93308 | 830 | 513 | $130K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5,378 | 4,364 | $127K |
| 82728 | 10,579 | 9,061 | $127K | |
| 97162 | 3,045 | 1,489 | $125K | |
| 93880 | 876 | 701 | $123K | |
| 72132 | 428 | 239 | $122K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 741 | 644 | $122K |
| 92526 | 1,801 | 983 | $122K | |
| 93922 | 964 | 753 | $122K | |
| 54360 | 375 | 366 | $121K | |
| 73552 | 1,501 | 1,224 | $121K | |
| 86920 | 1,498 | 1,107 | $120K | |
| 94060 | 1,009 | 732 | $120K | |
| 88360 | 682 | 522 | $120K | |
| J9171 | Injection, docetaxel, 1 mg | 92 | 64 | $116K |
| 72082 | 832 | 730 | $115K | |
| 71271 | 2,705 | 2,376 | $114K | |
| 88304 | 2,468 | 2,173 | $114K | |
| 78306 | 748 | 302 | $113K | |
| 97116 | 3,722 | 1,858 | $111K | |
| 85730 | 17,537 | 14,862 | $110K | |
| 99157 | 1,469 | 1,332 | $109K | |
| 92611 | 869 | 809 | $108K | |
| 95910 | 611 | 484 | $107K | |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 24 | 12 | $104K |
| 85027 | 19,598 | 15,786 | $103K | |
| 86900 | 17,360 | 13,081 | $101K | |
| 77072 | 1,034 | 979 | $101K | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 2,378 | 1,312 | $101K |
| 51797 | 678 | 658 | $101K | |
| 76825 | 460 | 424 | $101K | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 617 | 290 | $100K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 14,634 | 13,437 | $99K |
| 83605 | 6,292 | 4,992 | $99K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 616 | 554 | $99K |
| 77061 | 1,931 | 1,538 | $98K | |
| 73060 | 1,517 | 1,273 | $96K | |
| 77387 | 761 | 96 | $96K | |
| 77002 | 521 | 436 | $96K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,195 | 1,001 | $94K |
| 94726 | 913 | 822 | $93K | |
| 14040 | 302 | 279 | $93K | |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 474 | 468 | $93K |
| 36902 | 179 | 39 | $92K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 5,120 | 4,588 | $92K |
| 96416 | 424 | 247 | $92K | |
| 85610 | 21,010 | 17,274 | $91K | |
| 96409 | 773 | 447 | $90K | |
| 81001 | 35,945 | 31,576 | $90K | |
| 82803 | 3,189 | 2,625 | $89K | |
| C1760 | Closure device, vascular (implantable/insertable) | 223 | 188 | $87K |
| 95874 | 578 | 532 | $85K | |
| 73200 | 252 | 218 | $84K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,285 | 1,333 | $84K |
| 95911 | 351 | 275 | $82K | |
| 29580 | 1,920 | 580 | $81K | |
| 77075 | 261 | 247 | $81K | |
| J2323 | Injection, natalizumab, 1 mg | 14 | 12 | $80K |
| 95819 | 372 | 334 | $80K | |
| 10005 | 191 | 151 | $80K | |
| 42830 | 169 | 165 | $79K | |
| 70543 | 107 | 95 | $79K | |
| 95816 | 389 | 353 | $79K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3,358 | 3,046 | $79K |
| 64483 | 168 | 122 | $79K | |
| 84439 | 5,932 | 5,261 | $78K | |
| 96401 | 1,518 | 337 | $78K | |
| 84702 | 6,045 | 4,979 | $77K | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 3,521 | 3,273 | $76K |
| 92610 | 644 | 592 | $76K | |
| 77001 | 499 | 406 | $75K | |
| 94010 | 1,130 | 786 | $75K | |
| 91200 | 618 | 584 | $74K | |
| 72072 | 854 | 668 | $74K | |
| C1788 | Port, indwelling (implantable) | 198 | 184 | $73K |
| 87040 | 7,148 | 5,644 | $73K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 6,752 | 5,963 | $73K |
| 96402 | 872 | 659 | $72K | |
| 73140 | 1,201 | 1,099 | $72K | |
| 67311 | 90 | 78 | $72K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 9,938 | 6,308 | $71K |
| 54163 | 119 | 113 | $70K | |
| 82565 | 5,030 | 3,244 | $70K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 8,532 | 4,540 | $70K |
| A4648 | Tissue marker, implantable, any type, each | 766 | 485 | $67K |
| 77301 | 35 | 28 | $67K | |
| 80069 | 6,950 | 4,931 | $64K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 4,618 | 2,201 | $64K |
| 95806 | 549 | 479 | $63K | |
| 64493 | 133 | 99 | $63K | |
| 51741 | 485 | 471 | $63K | |
| 84112 | 900 | 797 | $62K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 379 | 296 | $62K |
| 82607 | 3,646 | 3,124 | $61K | |
| 93226 | 1,285 | 1,191 | $61K | |
| 72050 | 628 | 469 | $61K | |
| 12002 | 565 | 524 | $60K | |
| 86481 | 788 | 723 | $59K | |
| 73718 | 119 | 106 | $59K | |
| 90677 | 198 | 183 | $58K | |
| 86140 | 12,730 | 10,926 | $58K | |
| 84100 | 10,220 | 6,472 | $57K | |
| 84145 | 2,715 | 2,422 | $56K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,555 | 2,146 | $56K |
| 86901 | 15,849 | 12,935 | $56K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 18,807 | 11,662 | $56K |
| 76937 | 584 | 483 | $56K | |
| 95885 | 503 | 478 | $54K | |
| 10061 | 240 | 187 | $54K | |
| 72070 | 611 | 506 | $54K | |
| 85007 | 16,128 | 13,372 | $53K | |
| 83540 | 7,732 | 7,004 | $53K | |
| 90715 | 1,882 | 1,751 | $53K | |
| 94760 | 2,062 | 1,354 | $53K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 36,240 | 22,354 | $52K |
| 29125 | 579 | 511 | $52K | |
| 80074 | 1,131 | 963 | $51K | |
| 86902 | 1,394 | 754 | $51K | |
| 70480 | 134 | 121 | $51K | |
| 70360 | 821 | 780 | $50K | |
| 54304 | 68 | 68 | $50K | |
| 76000 | 437 | 358 | $50K | |
| 97166 | 776 | 662 | $50K | |
| 76800 | 282 | 275 | $50K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 44,638 | 30,469 | $49K |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 22 | 12 | $49K |
| J3489 | Injection, zoledronic acid, 1 mg | 585 | 496 | $49K |
| 94644 | 1,563 | 1,476 | $49K | |
| 86003 | 627 | 582 | $48K | |
| 43762 | 188 | 169 | $48K | |
| 97165 | 776 | 643 | $48K | |
| 72170 | 973 | 701 | $48K | |
| 99153 | Mod sedat endo service >5yrs | 600 | 516 | $47K |
| 81003 | 25,319 | 22,742 | $46K | |
| 87536 | 741 | 662 | $46K | |
| 82330 | 2,286 | 1,739 | $45K | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 4,219 | 710 | $45K |
| 77280 | 691 | 179 | $45K | |
| 64645 | 60 | 53 | $44K | |
| 71101 | 720 | 518 | $44K | |
| 70250 | 379 | 312 | $44K | |
| 31575 | 394 | 286 | $44K | |
| 94729 | 721 | 690 | $44K | |
| J9202 | Goserelin acetate implant, per 3.6 mg | 86 | 79 | $42K |
| C1729 | Catheter, drainage | 830 | 323 | $42K |
| 73080 | 701 | 513 | $41K | |
| 88313 | 545 | 450 | $41K | |
| 72195 | 72 | 66 | $41K | |
| 73000 | 618 | 548 | $40K | |
| 29581 | 781 | 191 | $39K | |
| 86922 | 625 | 436 | $39K | |
| 86870 | 557 | 384 | $39K | |
| 75565 | 94 | 89 | $39K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 20,214 | 7,484 | $38K |
| 95909 | 333 | 248 | $38K | |
| 93321 | 336 | 301 | $38K | |
| 31624 | 54 | 40 | $38K | |
| 25605 | 114 | 85 | $37K | |
| 36600 | 1,386 | 1,178 | $37K | |
| 82550 | 3,814 | 3,083 | $37K | |
| J3480 | Injection, potassium chloride, per 2 meq | 3,101 | 1,594 | $37K |
| 49500 | 12 | 12 | $37K | |
| 82784 | 2,605 | 2,131 | $36K | |
| 87070 | 4,140 | 3,339 | $36K | |
| 29881 | 57 | 28 | $36K | |
| 76857 | 420 | 320 | $36K | |
| 76942 | 221 | 178 | $35K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 6,591 | 2,775 | $35K |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 2,033 | 1,599 | $35K |
| 83970 | 995 | 863 | $35K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 51,227 | 35,791 | $35K |
| 83516 | 1,189 | 1,084 | $35K | |
| 86945 | 751 | 415 | $35K | |
| 99155 | 993 | 921 | $34K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 55 | 44 | $33K |
| 86923 | 1,063 | 768 | $33K | |
| 82150 | 2,770 | 2,404 | $33K | |
| 78708 | 111 | 99 | $32K | |
| 87077 | 4,699 | 4,226 | $32K | |
| 85379 | 4,298 | 3,969 | $32K | |
| 38222 | 205 | 55 | $32K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 189 | 179 | $31K |
| 86360 | 815 | 718 | $31K | |
| 72081 | 209 | 203 | $30K | |
| 29105 | 262 | 241 | $30K | |
| 77373 | 40 | 12 | $30K | |
| 64616 | 117 | 56 | $30K | |
| 94762 | 444 | 327 | $30K | |
| 72126 | 126 | 64 | $29K | |
| 97750 | 992 | 777 | $29K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 41,260 | 26,079 | $29K |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 353 | 106 | $28K |
| 95912 | 104 | 78 | $28K | |
| 97168 | 607 | 562 | $28K | |
| 99152 | 545 | 467 | $28K | |
| 87186 | 3,930 | 3,563 | $28K | |
| 82746 | 1,868 | 1,715 | $27K | |
| 83021 | 1,792 | 1,164 | $27K | |
| 72020 | 244 | 212 | $27K | |
| 97164 | 657 | 600 | $26K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 15,652 | 9,996 | $26K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,451 | 2,310 | $26K |
| 70470 | 87 | 49 | $26K | |
| 20930 | 44 | 37 | $25K | |
| 76604 | 234 | 210 | $25K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 991 | 855 | $25K |
| 64494 | 76 | 53 | $25K | |
| 26055 | 58 | 37 | $25K | |
| 96368 | 937 | 348 | $25K | |
| 76827 | 436 | 415 | $25K | |
| 87522 | Neg quan hep c or qual rna | 708 | 656 | $24K |
| 72083 | 184 | 162 | $24K | |
| 86664 | 1,251 | 1,020 | $23K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 6,481 | 5,124 | $23K |
| 90651 | 126 | 114 | $23K | |
| 85652 | 8,831 | 7,901 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,087 | 2,825 | $23K |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 2,883 | 2,323 | $22K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 30,793 | 23,127 | $22K |
| J9045 | Injection, carboplatin, 50 mg | 811 | 446 | $22K |
| 62328 | 52 | 50 | $22K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,698 | 1,105 | $22K |
| 73620 | 366 | 277 | $22K | |
| 11043 | 86 | 52 | $22K | |
| 84132 | 3,584 | 2,961 | $22K | |
| 83615 | 2,907 | 2,418 | $21K | |
| 86780 | 2,128 | 1,733 | $21K | |
| 87205 | 6,008 | 5,373 | $21K | |
| 94664 | 3,740 | 2,628 | $21K | |
| J1750 | Injection, iron dextran, 50 mg | 132 | 111 | $21K |
| 87529 | 525 | 432 | $20K | |
| 92523 | 209 | 176 | $20K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 3,496 | 1,899 | $20K |
| J0780 | Injection, prochlorperazine, up to 10 mg | 4,696 | 3,678 | $20K |
| 36591 | 987 | 707 | $20K | |
| 74170 | 31 | 25 | $20K | |
| 43245 | 75 | 29 | $20K | |
| 93976 | 161 | 144 | $19K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 3,074 | 2,274 | $19K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 177 | 167 | $19K |
| 62304 | 31 | 25 | $18K | |
| 74328 | 161 | 141 | $18K | |
| C9113 | Injection, pantoprazole sodium, per vial | 4,412 | 2,420 | $18K |
| J9070 | Cyclophosphamide, 100 mg | 35 | 27 | $18K |
| 85045 | 4,889 | 3,470 | $17K | |
| 72202 | 240 | 190 | $17K | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 2,828 | 708 | $17K |
| 88377 | 116 | 78 | $17K | |
| 95873 | 141 | 134 | $17K | |
| 82947 | 2,990 | 1,281 | $17K | |
| 64718 | 28 | 27 | $16K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 278 | 75 | $16K |
| C1763 | Connective tissue, non-human (includes synthetic) | 27 | 24 | $16K |
| 84156 | 2,615 | 2,175 | $16K | |
| 82810 | 185 | 130 | $16K | |
| 82378 | 741 | 560 | $16K | |
| 73720 | 18 | 14 | $16K | |
| 96450 | 80 | 54 | $16K | |
| 88302 | 511 | 440 | $15K | |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 180 | 174 | $15K |
| P9041 | Infusion, albumin (human), 5%, 50 ml | 241 | 189 | $15K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 674 | 544 | $15K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 5,057 | 3,516 | $15K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 3,084 | 1,019 | $15K |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 415 | 383 | $15K |
| J9190 | Injection, fluorouracil, 500 mg | 1,302 | 327 | $15K |
| 80197 | 950 | 615 | $15K | |
| 64635 | 20 | 12 | $15K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 369 | 340 | $15K |
| 86038 | 995 | 885 | $15K | |
| 86665 | 1,115 | 1,023 | $14K | |
| 88184 | 652 | 386 | $14K | |
| 74181 | 27 | 26 | $14K | |
| 93923 | 108 | 97 | $14K | |
| 87902 | 69 | 67 | $14K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 8,705 | 6,515 | $14K |
| 88312 | 296 | 259 | $14K | |
| 82785 | 609 | 571 | $14K | |
| 94645 | 370 | 345 | $14K | |
| 73660 | 249 | 227 | $13K | |
| 77338 | 35 | 28 | $13K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 835 | 545 | $13K |
| 87340 | 1,728 | 1,508 | $13K | |
| 43275 | 14 | 13 | $13K | |
| 82140 | 735 | 591 | $13K | |
| C2628 | Catheter, occlusion | 117 | 100 | $13K |
| 82570 | 2,538 | 2,225 | $12K | |
| 86803 | 1,151 | 1,063 | $12K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7,554 | 5,947 | $12K |
| 70260 | 83 | 81 | $12K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 580 | 549 | $12K |
| 94621 | 33 | 25 | $12K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 3,626 | 2,467 | $12K |
| 86147 | 293 | 241 | $12K | |
| C1758 | Catheter, ureteral | 444 | 378 | $12K |
| J9267 | Injection, paclitaxel, 1 mg | 307 | 161 | $12K |
| J1453 | Injection, fosaprepitant, 1 mg | 66 | 47 | $11K |
| 93312 | 66 | 28 | $11K | |
| 84460 | 2,159 | 1,974 | $11K | |
| 94618 | 342 | 301 | $11K | |
| 99156 | 511 | 448 | $11K | |
| 87075 | 1,199 | 1,036 | $11K | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,197 | 2,163 | $11K |
| 20610 | 52 | 40 | $11K | |
| 83655 | 865 | 828 | $11K | |
| 86706 | 1,223 | 1,125 | $11K | |
| 88112 | 256 | 197 | $10K | |
| 86663 | 1,110 | 1,020 | $10K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 1,637 | 1,001 | $10K |
| 84403 | 432 | 408 | $10K | |
| 90686 | 776 | 722 | $10K | |
| 77076 | 81 | 72 | $10K | |
| 43249 | 13 | 13 | $10K | |
| 86160 | 623 | 562 | $10K | |
| 86704 | 880 | 782 | $10K | |
| 87046 | 838 | 689 | $10K | |
| 86304 | 508 | 394 | $10K | |
| 64484 | 29 | 26 | $10K | |
| 85240 | 567 | 527 | $10K | |
| 80076 | 694 | 592 | $10K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 8,964 | 6,746 | $9K |
| 23350 | 40 | 40 | $9K | |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 256 | 141 | $9K |
| 27096 | 15 | 15 | $9K | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1,137 | 543 | $9K |
| 74270 | 41 | 39 | $9K | |
| 97167 | 125 | 107 | $9K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | 64 | 58 | $9K |
| 88173 | 151 | 127 | $9K | |
| 82010 | 1,162 | 998 | $9K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,870 | 1,293 | $9K |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 72 | 72 | $8K |
| 75573 | 15 | 15 | $8K | |
| 29826 | 17 | 12 | $8K | |
| 82533 | 471 | 383 | $8K | |
| 24640 | 64 | 62 | $8K | |
| 36416 | 1,613 | 1,155 | $8K | |
| 36590 | 21 | 12 | $8K | |
| 83550 | 1,069 | 986 | $8K | |
| 76506 | 48 | 42 | $8K | |
| 85576 | 265 | 227 | $8K | |
| 91320 | 95 | 84 | $8K | |
| 87210 | 3,850 | 3,593 | $8K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 361 | 166 | $8K |
| 76820 | 47 | 38 | $8K | |
| 84450 | 1,706 | 1,624 | $8K | |
| 72192 | 29 | 24 | $7K | |
| 84295 | 1,313 | 1,116 | $7K | |
| 85384 | 971 | 818 | $7K | |
| Q0222 | Injection, bebtelovimab, 175 mg | 21 | 12 | $7K |
| 84550 | 1,425 | 1,097 | $7K | |
| 87088 | 1,177 | 1,067 | $7K | |
| 82247 | 1,032 | 707 | $7K | |
| 87799 | 337 | 222 | $7K | |
| 86146 | 263 | 233 | $7K | |
| 83520 | 335 | 274 | $7K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 208 | 112 | $7K |
| J1953 | Injection, levetiracetam, 10 mg | 1,463 | 934 | $7K |
| 72220 | 106 | 88 | $7K | |
| 86301 | 443 | 302 | $7K | |
| 10120 | 33 | 30 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,022 | 950 | $7K |
| 75625 | 22 | 17 | $7K | |
| 85347 | 600 | 502 | $7K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 645 | 563 | $6K |
| 96523 | 333 | 262 | $6K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 222 | 78 | $6K |
| 22853 | 14 | 13 | $6K | |
| 86334 | 397 | 359 | $6K | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 407 | 292 | $6K |
| 73222 | 16 | 12 | $6K | |
| 87045 | 792 | 742 | $6K | |
| 72052 | 47 | 42 | $6K | |
| 80164 | 431 | 353 | $6K | |
| 83521 | 321 | 235 | $6K | |
| 85014 | 2,220 | 1,559 | $6K | |
| 87427 | 699 | 656 | $6K | |
| 19081 | 35 | 12 | $6K | |
| 84165 | 702 | 613 | $6K | |
| 90688 | 577 | 520 | $6K | |
| 80143 | 364 | 323 | $6K | |
| 82248 | 1,191 | 870 | $6K | |
| J3411 | Injection, thiamine hcl, 100 mg | 1,437 | 1,015 | $5K |
| 86800 | 450 | 423 | $5K | |
| 83010 | 387 | 340 | $5K | |
| 82435 | 855 | 735 | $5K | |
| 59820 | 12 | 12 | $5K | |
| 86308 | 1,355 | 1,264 | $5K | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 973 | 276 | $5K |
| J9370 | Vincristine sulfate, 1 mg | 769 | 431 | $5K |
| 82945 | 686 | 545 | $5K | |
| 29827 | 17 | 12 | $5K | |
| 85660 | 886 | 563 | $5K | |
| 82977 | 705 | 589 | $5K | |
| 85018 | 2,424 | 1,788 | $5K | |
| 86235 | 88 | 77 | $5K | |
| P9073 | Platelets, pheresis, pathogen-reduced, each unit | 23 | 12 | $5K |
| 82270 | 1,445 | 796 | $5K | |
| 84153 | 195 | 175 | $5K | |
| 80179 | 360 | 320 | $5K | |
| 73100 | 97 | 71 | $5K | |
| 83921 | 293 | 269 | $5K | |
| 99195 | 149 | 110 | $5K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1,110 | 830 | $5K |
| 88182 | 125 | 95 | $5K | |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 195 | 185 | $4K |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 840 | 348 | $4K |
| 83930 | 715 | 552 | $4K | |
| 89051 | 1,070 | 848 | $4K | |
| 84146 | 253 | 239 | $4K | |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 131 | 39 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 421 | 376 | $4K |
| 12013 | 45 | 41 | $4K | |
| J0694 | Injection, cefoxitin sodium, 1 gm | 421 | 311 | $4K |
| 86703 | 423 | 386 | $4K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 7,174 | 2,279 | $4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 74 | 71 | $4K |
| 94667 | 155 | 143 | $4K | |
| J0248 | Injection, remdesivir, 1 mg | 51 | 26 | $4K |
| 74220 | 30 | 24 | $4K | |
| 84157 | 725 | 583 | $4K | |
| 80202 | 281 | 180 | $4K | |
| 85597 | 488 | 275 | $4K | |
| J1940 | Injection, furosemide, up to 20 mg | 1,917 | 920 | $4K |
| 85245 | 193 | 184 | $4K | |
| J0456 | Injection, azithromycin, 500 mg | 974 | 598 | $3K |
| 88300 | 217 | 183 | $3K | |
| J3360 | Injection, diazepam, up to 5 mg | 330 | 165 | $3K |
| 82310 | 390 | 326 | $3K | |
| 84481 | 182 | 175 | $3K | |
| 88311 | 208 | 183 | $3K | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 2,654 | 1,289 | $3K |
| G0008 | Administration of influenza virus vaccine | 187 | 172 | $3K |
| Q3014 | Telehealth originating site facility fee | 182 | 155 | $3K |
| 90739 | 32 | 28 | $3K | |
| 87497 | 118 | 91 | $3K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 2,757 | 1,794 | $3K |
| 87102 | 424 | 354 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 81 | 79 | $3K |
| 87901 | 15 | 12 | $3K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 269 | 193 | $3K |
| 84305 | 171 | 166 | $3K | |
| 95711 | 76 | 71 | $3K | |
| 86200 | 243 | 225 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 26 | 25 | $3K |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | 49 | 41 | $3K |
| 69200 | 40 | 39 | $3K | |
| 86592 | 510 | 409 | $3K | |
| 90461 | 213 | 197 | $3K | |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 136 | 67 | $3K |
| 86225 | 315 | 298 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 3,042 | 2,271 | $3K |
| J2060 | Injection, lorazepam, 2 mg | 2,613 | 1,977 | $3K |
| 88331 | 49 | 37 | $2K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 1,717 | 1,476 | $2K |
| 86762 | 254 | 230 | $2K | |
| 85397 | 111 | 107 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2,058 | 637 | $2K |
| 77399 | 36 | 32 | $2K | |
| 83001 | 141 | 129 | $2K | |
| 87899 | 189 | 177 | $2K | |
| 81002 | 247 | 205 | $2K | |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 32 | 15 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 3,260 | 2,271 | $2K |
| 87015 | 427 | 338 | $2K | |
| 87116 | 306 | 242 | $2K | |
| 87177 | 270 | 248 | $2K | |
| J2805 | Injection, sincalide, 5 micrograms | 77 | 68 | $2K |
| 85244 | 126 | 116 | $2K | |
| 80177 | 201 | 182 | $2K | |
| 69209 | 14 | 14 | $2K | |
| 82525 | 134 | 114 | $2K | |
| 86431 | 442 | 407 | $2K | |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 27 | 26 | $2K |
| 86708 | 238 | 204 | $2K | |
| 85613 | 299 | 274 | $2K | |
| 76828 | 16 | 12 | $2K | |
| J1171 | Injection, hydromorphone, 0.1 mg | 1,267 | 523 | $2K |
| 29505 | 12 | 12 | $2K | |
| J1956 | Injection, levofloxacin, 250 mg | 395 | 276 | $2K |
| 86341 | 45 | 41 | $2K | |
| 30300 | 27 | 25 | $2K | |
| 76826 | 16 | 12 | $2K | |
| 86757 | 63 | 51 | $2K | |
| 84480 | 129 | 117 | $2K | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 149 | 138 | $2K |
| 87900 | 15 | 12 | $2K | |
| 85246 | 101 | 97 | $2K | |
| J1790 | Injection, droperidol, up to 5 mg | 976 | 861 | $2K |
| 86618 | 100 | 79 | $2K | |
| 87081 | 274 | 245 | $2K | |
| 82043 | 333 | 309 | $2K | |
| 86376 | 85 | 75 | $2K | |
| 87449 | 204 | 190 | $2K | |
| 83002 | 83 | 77 | $1K | |
| 84270 | 79 | 77 | $1K | |
| 81243 | 48 | 47 | $1K | |
| 82397 | 89 | 89 | $1K | |
| 88108 | 69 | 53 | $1K | |
| 99215 | Prolong outpt/office vis | 51 | 44 | $1K |
| 0279U | 97 | 93 | $1K | |
| 82657 | 43 | 25 | $1K | |
| 86593 | 246 | 229 | $1K | |
| 84134 | 147 | 118 | $1K | |
| 84432 | 111 | 91 | $1K | |
| 94625 | 139 | 24 | $1K | |
| J0461 | Injection, atropine sulfate, 0.01 mg | 178 | 104 | $1K |
| J2470 | Injection, pantoprazole sodium, 40 mg | 529 | 258 | $1K |
| 86617 | 65 | 46 | $1K | |
| 84436 | 195 | 179 | $1K | |
| 86812 | 42 | 41 | $1K | |
| J2598 | Injection, vasopressin, 1 unit | 21 | 12 | $1K |
| 86039 | 131 | 121 | $1K | |
| 94668 | 19 | 12 | $988.20 | |
| 87498 | 40 | 38 | $947.43 | |
| 87206 | 300 | 235 | $944.44 | |
| J0290 | Injection, ampicillin sodium, 500 mg | 201 | 83 | $908.13 |
| 82668 | 61 | 52 | $897.72 | |
| 82805 | 13 | 13 | $894.05 | |
| A9270 | Non-covered item or service | 7,805 | 1,573 | $878.25 |
| 84681 | 78 | 69 | $876.10 | |
| 83525 | 84 | 81 | $833.03 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 44 | 26 | $798.08 |
| 86705 | 83 | 77 | $781.03 | |
| 84300 | 230 | 186 | $757.02 | |
| 86880 | 79 | 53 | $748.38 | |
| 82670 | 27 | 27 | $748.08 | |
| 87496 | 27 | 26 | $701.80 | |
| 83986 | 196 | 179 | $689.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 90 | 84 | $686.90 |
| 83498 | 30 | 26 | $671.38 | |
| 87532 | 26 | 25 | $666.71 | |
| 86644 | 31 | 27 | $660.45 | |
| 82180 | 74 | 67 | $628.30 | |
| 82985 | 60 | 59 | $621.38 | |
| 85303 | 88 | 68 | $595.15 | |
| 83876 | 16 | 14 | $559.46 | |
| 82627 | 26 | 24 | $545.52 | |
| J3372 | Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg | 87 | 42 | $539.58 |
| 82365 | 52 | 50 | $519.13 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 153 | 114 | $480.04 |
| 84402 | 28 | 28 | $479.07 | |
| 90656 | 36 | 33 | $462.73 | |
| 0124A | 20 | 14 | $440.14 | |
| 82652 | 12 | 12 | $439.70 | |
| 93271 | 18 | 14 | $435.40 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 95 | 89 | $424.33 |
| 88333 | 14 | 12 | $419.86 | |
| 85300 | 55 | 49 | $417.95 | |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 35 | 26 | $410.89 |
| J9260 | Injection, methotrexate sodium, 50 mg | 226 | 141 | $403.99 |
| 82379 | 29 | 27 | $392.91 | |
| 82164 | 13 | 13 | $378.67 | |
| 84630 | 57 | 40 | $368.35 | |
| 90662 | 106 | 100 | $357.44 | |
| 84238 | 12 | 12 | $329.13 | |
| 86355 | 19 | 13 | $301.84 | |
| 86359 | 21 | 14 | $301.84 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 28 | 28 | $297.41 |
| 86645 | 13 | 12 | $294.70 | |
| 84207 | 15 | 13 | $282.41 | |
| 85306 | 29 | 26 | $235.00 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 16 | 13 | $228.23 |
| 84075 | 13 | 12 | $209.88 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 278 | 210 | $194.41 |
| 82105 | 13 | 13 | $184.47 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 99 | 84 | $173.00 |
| 83993 | 12 | 12 | $162.64 | |
| 86682 | 13 | 12 | $158.33 | |
| 87106 | 14 | 12 | $113.52 | |
| J1630 | Injection, haloperidol, up to 5 mg | 158 | 123 | $108.34 |
| 86008 | 13 | 12 | $107.58 | |
| 84133 | 30 | 28 | $96.68 | |
| C8937 | Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) | 321 | 288 | $32.04 |
| A0425 | Ground mileage, per statute mile | 42 | 32 | $1.74 |
| 91312 | 20 | 14 | $0.12 | |
| T2005 | Non-emergency transportation; stretcher van | 16 | 13 | $0.00 |